A carregar...

Effect of Certolizumab Pegol on Multiple Facets of Psoriatic Arthritis as Reported by Patients: 24-Week Patient-Reported Outcome Results of a Phase III, Multicenter Study

OBJECTIVE: To examine the effect of certolizumab pegol (CZP) on patient-reported outcomes (PROs) in psoriatic arthritis (PsA) patients with and without prior tumor necrosis factor (TNF) inhibitor exposure. METHODS: The ongoing phase III RAPID-PsA trial was double blind and placebo controlled to week...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gladman, D, Fleischmann, R, Coteur, G, Woltering, F, Mease, P J
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171746/
https://ncbi.nlm.nih.gov/pubmed/24339179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.22256
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!